Release Date: February 10, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Femcare sales have been weak, and you've mentioned consolidating the brand portfolio. Can you explain why the business is still struggling and if the spring resets will help? A: The category is healthy overall, driven by pads, where we're currently challenged. We've been transitioning consumers from Stay Free to Carefree pads, which is taking longer than expected. However, we're making progress, and results should improve sequentially throughout the year due to easier comparisons and ongoing consumer conversion efforts.
Q: Can you provide context on the businesses experiencing atypically negative performance and when they might improve? A: Improvement is expected primarily in the second half of the year. Supply chain issues from last year, like the fire in our manufacturing plant, are being resolved. Wet Ones is already back online, and other areas like EDGE and Cremo will start to improve as we lap those periods in the summer.
Q: FX is a bigger hit this year. What are your plans to offset this, and are you considering pricing changes? A: The FX impact is heavier than anticipated, but we're maintaining our profit guidance within the original ranges. While we've executed planned pricing for 2025, we are focusing on revenue management, optimizing trade terms, and managing mix. We are not planning to cut brand investments to offset FX impacts.
Q: How do you view your position in the sun care market as we head into the peak season? A: We feel well-positioned for the sun season with strong distribution and innovation. We're optimistic about weather patterns and have good retailer support. Internationally, we've seen strong performance, winning market share in Australia and Mexico. Our innovation pipeline, including a complete mineral restage in the US, is robust.
Q: What are your updated thoughts on capital allocation and potential M&A? A: We've been focusing on deleveraging and share buybacks, but M&A remains important for growth. We're active in the market, though valuations are challenging. We wouldn't shy away from acquisitions that are meaningful to our growth. Share repurchase is also a good use of capital given our current valuation.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.